Search results
If a medicine causes damage to your liver, this is called Drug Induced Liver Injury or DILI. Your liver has an amazing ability to repair itself when it has been damaged. So, most people will fully recover from drug induced liver injury. But recovery can take time.
Idiosyncratic drug-induced liver injury (DILI) is an unpredictable type of liver injury following exposure to medication within the recommended dose which is distinctive from liver injury caused by drug overdosage, commonly caused by paracetamol overdose (POD).
Apr 14, 2023 · A high index of suspicion is often necessary to expeditiously establish the diagnosis. This topic will review the epidemiology, clinical manifestations, diagnosis, and management of drug-induced liver injury (DILI).
Idiosyncratic drug-induced liver injury (IDILI) is a rare but potentially severe adverse drug reaction that should be considered in patients who develop laboratory criteria for liver injury secondary to the administration of a potentially hepatotoxic drug.
- Gerd A Kullak-Ublick, Raul J Andrade, Michael Merz, Peter End, Andreas Benesic, Alexander L Gerbes, ...
- 2017
A meta-analysis of results from candidate gene studies investigating drug-metabolising enzyme (DME) polymorphisms on the risk of anti-TBC DILI showed a substantial variation in association between SNPs in N-acetyltransferase 2 (NAT2) and DILI.
- Raúl J. Andrade, Guruprasad P. Aithal, Einar S. Björnsson, Neil Kaplowitz, Gerd A. Kullak-Ublick, Do...
- 2019
Sep 10, 2024 · The pathogenesis of DILI can be divided into 2 mechanisms: intrinsic and idiosyncratic. The intrinsic mechanism is both predictable and reproducible from drugs that are known to cause liver injury in a dose-dependent manner with a short latency period.
People also ask
What is drug-induced liver injury (DILI)?
How is Dili classified?
What does Dili stand for?
What is the pathogenesis of Dili?
Does Dili cause liver damage?
What is idiosyncratic drug-induced liver injury (DILI)?
At a regulatory level, drug-induced liver injury (DILI) is the commonest reason for withdrawing drugs from the market and/or issuing warnings and modification of use. DILI is classified as either predictable or unpredictable (idiosyncratic).